Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Mehmet Bostancıklıoğlu. Beteiligte Einrichtung: Institute of Experimental and Clinical Research, Pole of Endocrinology, Diabetes and Nutrition, Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Hallucinogens, Islets of Langerhans. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Research, Pole of Endocrinology, Diabetes and Nutrition, Université Catholique de Louvain, Brussels, Belgium.
ORCID-Profile: Mehmet Bostancıklıoğlu
Zitieren
APA
Bostancıklıoğlu, M. (2024). Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15411
Vancouver
Bostancıklıoğlu M. Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15411
BibTeX
@article{Bostancklolu2024,
author = {Bostancıklıoğlu, Mehmet},
title = {Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15411}
}
EUVIMED